Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tango Therapeutics (TNGX) Tax Provisions (2020 - 2025)

Tango Therapeutics (TNGX) has 5 years of Tax Provisions data on record, last reported at $41000.0 in Q4 2024.

  • For Q4 2024, Tax Provisions rose 20.59% year-over-year to $41000.0; the TTM value through Dec 2024 reached $200000.0, up 49.25%, while the annual FY2025 figure was $4000.0, 98.0% down from the prior year.
  • Tax Provisions reached $41000.0 in Q4 2024 per TNGX's latest filing, down from $54000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $177000.0 in Q4 2021 and bottomed at -$21000.0 in Q2 2021.
  • Average Tax Provisions over 5 years is $55990.3, with a median of $52500.0 recorded in 2022.
  • Peak YoY movement for Tax Provisions: soared 2478.67% in 2021, then tumbled 71.19% in 2022.
  • A 5-year view of Tax Provisions shows it stood at $6864.0 in 2020, then skyrocketed by 2478.67% to $177000.0 in 2021, then crashed by 71.19% to $51000.0 in 2022, then plummeted by 33.33% to $34000.0 in 2023, then rose by 20.59% to $41000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $41000.0 in Q4 2024, $54000.0 in Q3 2024, and $65000.0 in Q2 2024.